Amyotrophic lateral sclerosis affects everyone differently, but it causes a gradual loss of control in your voluntary muscles -- the ones you use to walk, talk, move, speak, eat, drink, and breathe.

Dementia in ALS Overview Amyotrophic lateral sclerosis (ALS) is a devastating disease that affects the part of the nervous system that controls voluntary movements. ALS is also called Lou Gehrig's ...

Am J Manag Care. 2018;24:-S0 Amyotrophic lateral sclerosis (ALS) is a disease that results in the progressive deterioration and loss of function of the motor neurons in the brain and spinal cord ...

Amyotrophic lateral sclerosis Amyotrophic lateral sclerosis (ALS) is characterized by the degeneration of both upper and lower motor neurons, which leads to progressive muscle weakness and paralysis.

Amyotrophic lateral sclerosis, or Lou Gehrig's disease, causes progressive muscle weakening. Learn more here.

Amyotrophic lateral sclerosis, often referred to as "Lou Gehrig's disease," is a progressive neurodegenerative disease that attacks nerve cells in the brain and the spinal cord. Motor neurons reach ...

Increased consumer and medical professional knowledge regarding novel treatments is predicted to drive growth in the global amyotrophic lateral sclerosis (ALS) treatment market. The introduction ...

Vancouver, Aug. 29, 2023 (GLOBE NEWSWIRE) -- The worldwide market for amyotrophic lateral sclerosis achieved a size of USD 613.0 million in the year 2022. According to the most recent study ...

Amyotrophic lateral sclerosis (ALS) is a degenerative disease that affects motor neurons. It causes loss of control of voluntary muscles. Read on to learn more.

Brain MRI scans can help medical professionals diagnose and track the progress of amyotrophic lateral sclerosis (ALS). Learn more about how it works here.

Brian Wallach has beaten the odds after being diagnosed with ALS (amyotrophic lateral sclerosis, or Lou Gehrig's disease) six years ago. Since then, he and his wife, Sandra, have successfully ...

Amyotrophic Lateral Sclerosis, ALS, is a horrible disease. Last week in a reversal of a decision the FDA made just a few months ago, their external advisory board approved a “novel” drug for ALS. What ...